Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × aldesleukin × 90 days × Clear all

Sponsor

Conditions

Melanoma 7 Neoplasm Metastasis 5 Carcinoma, Renal Cell 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 3 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid 2 Leukemia 2 Colorectal Neoplasms 2 Carcinoma, Merkel Cell 2 Vulvar Diseases 1 Vaginal Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Penile Neoplasms 1 Papillomavirus Infections 1

Interventions

trametinib 2 dabrafenib 2 pembrolizumab 1 cobimetinib 1 atezolizumab 1 Vemurafenib 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Paclitaxel 1 Immunoglobulin G 1 Disulfides 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡